Review




Structured Review

Galectin Therapeutics galectin 3 nlrp3 il 1β signaling pathway
Galectin 3 Nlrp3 Il 1β Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/pm42105955-102-47-47
Average 86 stars, based on 1 article reviews
galectin 3 nlrp3 il 1β signaling pathway - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

other:

Article Title: Heart failure subtype after acute kidney injury.
Article Snippet: Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway.



Similar Products

86
Galectin Therapeutics galectin 3 nlrp3 il 1β signaling pathway
Galectin 3 Nlrp3 Il 1β Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/pm42105955-102-47-47
Average 86 stars, based on 1 article reviews
galectin 3 nlrp3 il 1β signaling pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics tim 3 galectin 9 pathway
Tim 3 Galectin 9 Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/lgals3/us12590062-678-1-1
Average 86 stars, based on 1 article reviews
tim 3 galectin 9 pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics apoe galectin 3 signaling pathway
Apoe Galectin 3 Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/lgals3/pm41803887-394-7-7
Average 86 stars, based on 1 article reviews
apoe galectin 3 signaling pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 3 signaling pathway
Galectin 3 Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/galectin+pathways/pm41803887-100-9-9
Average 86 stars, based on 1 article reviews
galectin 3 signaling pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics apoe galectin 3 dependent pathway
Apoe Galectin 3 Dependent Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/pm41803887-377-14-14
Average 86 stars, based on 1 article reviews
apoe galectin 3 dependent pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 3 akt gsk 3β snail signaling pathway
Galectin 3 Akt Gsk 3β Snail Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/lgals3/pm41594603-151-12-12
Average 86 stars, based on 1 article reviews
galectin 3 akt gsk 3β snail signaling pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 3 kras ralb tbk1 nf κb signaling pathway
Galectin 3 Kras Ralb Tbk1 Nf κb Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/pmc12833063-25-10-10
Average 86 stars, based on 1 article reviews
galectin 3 kras ralb tbk1 nf κb signaling pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 3 pathways
Receiver operating characteristic (ROC) curves of serum YKL-40 <t>and</t> <t>Galectin-3</t> for predicting proliferative vitreoretinopathy (PVR) development in rhegmatogenous retinal detachment (RRD) (a) ROC curve of serum YKL-40 demonstrating good discriminative performance for predicting PVR (AUC = 0.739, 95% CI = 0.621–0.856, p = 0.001; optimal cut-off = 26.9 ng/mL, sensitivity = 68.8%, specificity = 67.6%) (b) ROC curve of serum Galectin-3 showing moderate predictive accuracy (AUC = 0.643, 95% CI = 0.510–0.777, p = 0.045; optimal cut-off = 99.7 pg/mL, sensitivity = 62.5%, specificity = 58.8%) The diagonal line represents the reference line for random classification (AUC = 0.5)
Galectin 3 Pathways, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/pmc12797585-184-16-16
Average 86 stars, based on 1 article reviews
galectin 3 pathways - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 9 tim 3 pathways
Receiver operating characteristic (ROC) curves of serum YKL-40 <t>and</t> <t>Galectin-3</t> for predicting proliferative vitreoretinopathy (PVR) development in rhegmatogenous retinal detachment (RRD) (a) ROC curve of serum YKL-40 demonstrating good discriminative performance for predicting PVR (AUC = 0.739, 95% CI = 0.621–0.856, p = 0.001; optimal cut-off = 26.9 ng/mL, sensitivity = 68.8%, specificity = 67.6%) (b) ROC curve of serum Galectin-3 showing moderate predictive accuracy (AUC = 0.643, 95% CI = 0.510–0.777, p = 0.045; optimal cut-off = 99.7 pg/mL, sensitivity = 62.5%, specificity = 58.8%) The diagonal line represents the reference line for random classification (AUC = 0.5)
Galectin 9 Tim 3 Pathways, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/lgals3/pmc12524148-205-23-23
Average 86 stars, based on 1 article reviews
galectin 9 tim 3 pathways - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics pten yap galectin 3 signaling pathway
Receiver operating characteristic (ROC) curves of serum YKL-40 <t>and</t> <t>Galectin-3</t> for predicting proliferative vitreoretinopathy (PVR) development in rhegmatogenous retinal detachment (RRD) (a) ROC curve of serum YKL-40 demonstrating good discriminative performance for predicting PVR (AUC = 0.739, 95% CI = 0.621–0.856, p = 0.001; optimal cut-off = 26.9 ng/mL, sensitivity = 68.8%, specificity = 67.6%) (b) ROC curve of serum Galectin-3 showing moderate predictive accuracy (AUC = 0.643, 95% CI = 0.510–0.777, p = 0.045; optimal cut-off = 99.7 pg/mL, sensitivity = 62.5%, specificity = 58.8%) The diagonal line represents the reference line for random classification (AUC = 0.5)
Pten Yap Galectin 3 Signaling Pathway, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin+3+pathway/pm41053273-22-2-2
Average 86 stars, based on 1 article reviews
pten yap galectin 3 signaling pathway - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Receiver operating characteristic (ROC) curves of serum YKL-40 and Galectin-3 for predicting proliferative vitreoretinopathy (PVR) development in rhegmatogenous retinal detachment (RRD) (a) ROC curve of serum YKL-40 demonstrating good discriminative performance for predicting PVR (AUC = 0.739, 95% CI = 0.621–0.856, p = 0.001; optimal cut-off = 26.9 ng/mL, sensitivity = 68.8%, specificity = 67.6%) (b) ROC curve of serum Galectin-3 showing moderate predictive accuracy (AUC = 0.643, 95% CI = 0.510–0.777, p = 0.045; optimal cut-off = 99.7 pg/mL, sensitivity = 62.5%, specificity = 58.8%) The diagonal line represents the reference line for random classification (AUC = 0.5)

Journal: BMC Ophthalmology

Article Title: Evaluation of serum YKL-40 and Galectin-3 as predictive biomarkers for proliferative vitreoretinopathy in rhegmatogenous retinal detachment: a prospective comparative study

doi: 10.1186/s12886-025-04553-3

Figure Lengend Snippet: Receiver operating characteristic (ROC) curves of serum YKL-40 and Galectin-3 for predicting proliferative vitreoretinopathy (PVR) development in rhegmatogenous retinal detachment (RRD) (a) ROC curve of serum YKL-40 demonstrating good discriminative performance for predicting PVR (AUC = 0.739, 95% CI = 0.621–0.856, p = 0.001; optimal cut-off = 26.9 ng/mL, sensitivity = 68.8%, specificity = 67.6%) (b) ROC curve of serum Galectin-3 showing moderate predictive accuracy (AUC = 0.643, 95% CI = 0.510–0.777, p = 0.045; optimal cut-off = 99.7 pg/mL, sensitivity = 62.5%, specificity = 58.8%) The diagonal line represents the reference line for random classification (AUC = 0.5)

Article Snippet: Future research integrating paired serum and vitreous analyses, longitudinal follow-up, and targeted inhibition of YKL-40 or Galectin-3 pathways could clarify whether these biomarkers act as active mediators or downstream indicators of fibrosis.

Techniques: